Total Payments
$22,785
2024 Payments
$2,112
Companies
45
Transactions
313
Medicare Patients
6,117
Medicare Billing
$917,424
Payment Breakdown by Category
Other$12,140 (53.3%)
Food & Beverage$9,217 (40.5%)
Travel$1,419 (6.2%)
Education$7.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,217 | 302 | 40.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,140 | 1 | 31.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,000 | 1 | 21.9% |
| Travel and Lodging | $1,419 | 6 | 6.2% |
| Education | $7.68 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $8,738 | 39 | $0 (2020) |
| Medtronic, Inc. | $7,071 | 44 | $0 (2024) |
| Boston Scientific Corporation | $2,020 | 30 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,071 | 58 | $0 (2024) |
| Vertos Medical, Inc. | $502.62 | 20 | $0 (2024) |
| Abbott Laboratories | $311.30 | 10 | $0 (2022) |
| Spinal Simplicity, LLC | $305.83 | 2 | $0 (2022) |
| SI-BONE, Inc. | $300.84 | 3 | $0 (2019) |
| MML US, Inc. | $266.16 | 2 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $227.40 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,112 | 32 | Boston Scientific Corporation ($1,216) |
| 2023 | $2,170 | 57 | Medtronic, Inc. ($996.55) |
| 2022 | $6,194 | 27 | Medtronic, Inc. ($5,651) |
| 2021 | $702.41 | 34 | Medtronic, Inc. ($212.58) |
| 2020 | $356.09 | 18 | Medtronic USA, Inc. ($69.82) |
| 2019 | $777.90 | 33 | SI-BONE, Inc. ($181.68) |
| 2018 | $9,297 | 63 | Medtronic USA, Inc. ($8,122) |
| 2017 | $1,176 | 49 | Medtronic USA, Inc. ($415.43) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Opioid Analgesic | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Opioid Analgesic | ||||||
| 09/23/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $307.00 | General |
| Category: General - Therapies_NMD | ||||||
| 09/21/2024 | Boston Scientific Corporation | Infinion 16 (Device) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Infinion_NMD | ||||||
| 09/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/20/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $637.95 | General |
| Category: General - Therapies_NMD | ||||||
| 09/20/2024 | Boston Scientific Corporation | Infinion 16 (Device) | Food and Beverage | In-kind items and services | $109.13 | General |
| Category: Infinion_NMD | ||||||
| 09/20/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/20/2024 | Boston Scientific Corporation | Infinion 16 (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Infinion_NMD | ||||||
| 08/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $48.63 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $37.94 | General |
| Category: Orthopedic | ||||||
| 08/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Opioid Analgesic | ||||||
| 07/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $59.32 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Opioid Analgesic | ||||||
| 06/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: Opioid Analgesic | ||||||
| 05/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: Opioid Analgesic | ||||||
| 05/13/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $73.52 | General |
| Category: Orthopedic | ||||||
| 04/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,505 | 1,947 | $1.0M | $201,432 |
| 2022 | 19 | 1,397 | 2,098 | $1.1M | $195,815 |
| 2021 | 24 | 1,752 | 3,040 | $1.8M | $286,095 |
| 2020 | 25 | 1,463 | 2,520 | $1.5M | $234,082 |
Total Patients
6,117
Total Services
9,605
Medicare Billing
$917,424
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 215 | 398 | $256,620 | $46,364 | 18.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 112 | 140 | $150,150 | $25,701 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $93,960 | $20,872 | 22.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 161 | 188 | $102,610 | $18,981 | 18.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 71 | 72 | $54,000 | $17,423 | 32.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 161 | 188 | $59,580 | $10,690 | 17.9% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 11 | 32 | $46,080 | $8,615 | 18.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 112 | 144 | $39,800 | $7,941 | 20.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 64 | 101 | $37,370 | $7,376 | 19.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 27 | 33 | $35,880 | $6,173 | 17.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 81 | 136 | $24,480 | $5,617 | 22.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 45 | 48 | $30,710 | $5,616 | 18.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 72 | 74 | $14,060 | $4,507 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 43 | $19,350 | $4,409 | 22.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 45 | 48 | $17,430 | $3,166 | 18.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 27 | 33 | $10,580 | $2,149 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 29 | $9,280 | $2,051 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $6,240 | $1,476 | 23.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 25 | 29 | $5,920 | $1,181 | 19.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Facility | 2023 | 15 | 15 | $4,200 | $742.53 | 17.7% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 17 | 18 | $7,740 | $381.41 | 4.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 224 | 434 | $301,110 | $50,063 | 16.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 117 | 173 | $149,640 | $27,804 | 18.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 147 | 166 | $99,050 | $16,864 | 17.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 116 | 277 | $101,800 | $13,710 | 13.5% |
About Dr. Richard Brouillette, DO
Dr. Richard Brouillette, DO is a Interventional Pain Medicine healthcare provider based in Waldorf, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063626836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Brouillette, DO has received a total of $22,785 in payments from pharmaceutical and medical device companies, with $2,112 received in 2024. These payments were reported across 313 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,217).
As a Medicare-enrolled provider, Brouillette has provided services to 6,117 Medicare beneficiaries, totaling 9,605 services with total Medicare billing of $917,424. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Waldorf, MD
- Active Since 05/10/2007
- Last Updated 06/18/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1063626836
Products in Payments
- INTELLIS (Device) $8,495
- SYNCHROMEDII (Device) $5,000
- INTELLIS ADAPTIVESTIM (Device) $1,716
- XTAMPZA (Drug) $692.06
- mild Device Kit (Device) $502.62
- RESTORE (Device) $438.49
- Infinion 16 (Device) $399.73
- WaveWriter Alpha Prime 16 (Device) $343.38
- HA MINUTEMAN G3-R (Device) $305.83
- iFuse Implant (Device) $300.84
- ReActiv8 (Device) $266.16
- Senza Spinal Cord Stimulation System (Device) $184.40
- Belbuca (Drug) $180.98
- Infinion 16 (Device) $160.22
- LORZONE (Drug) $159.67
- Xtampza ER (Drug) $135.94
- Amitiza (Drug) $122.82
- Nalu Neurostimulation System (Device) $116.94
- Proclaim IPG (Device) $114.13
- StimQ Receiver Stimulator Kit Channel A US w Receiver (Device) $110.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.